Detalhe da pesquisa
1.
Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology.
J Immunol
; 210(9): 1257-1271, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881867
2.
A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.
Proc Natl Acad Sci U S A
; 119(33): e2201616119, 2022 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895717
3.
SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern.
Proc Natl Acad Sci U S A
; 119(35): e2110105119, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35994646
4.
A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike.
Proc Natl Acad Sci U S A
; 118(12)2021 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33688034
5.
A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.
J Virol
; 95(20): e0059221, 2021 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379509
6.
Five Residues in the Apical Loop of the Respiratory Syncytial Virus Fusion Protein F2 Subunit Are Critical for Its Fusion Activity.
J Virol
; 92(15)2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29743373
7.
Molecular mechanism of respiratory syncytial virus fusion inhibitors.
Nat Chem Biol
; 12(2): 87-93, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26641933
8.
Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection.
J Infect Dis
; 216(11): 1398-1406, 2017 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029312
9.
Soluble respiratory syncytial virus fusion protein in the fully cleaved, pretriggered state is triggered by exposure to low-molarity buffer.
J Virol
; 85(8): 3968-77, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21307202
10.
Targeting RSV with vaccines and small molecule drugs.
Infect Disord Drug Targets
; 12(2): 110-28, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22335496